Consonance Capital Management LP Cytokinetics Inc Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$20.58 - $28.96 $68.9 Million - $96.9 Million
-3,347,232 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$11.15 - $24.64 $947,750 - $2.09 Million
-85,000 Reduced 2.48%
3,347,232 $78.9 Million
Q1 2020

May 15, 2020
BUY
$8.75 - $16.3 $30 Million - $55.9 Million
3,432,232 New
3,432,232 $40.5 Million

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.57B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email